Drug
Lurasidone clinical trials
Also written Latuda and SM-13496.
- studies test it
- 66
- open now
- 4
- in phase 3
- 35
- first study started
- 2002
Keep track of what changes. Save the lurasidone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Latuda
- 21
Studies by the year they started
66 studies that test it; most in 2008 (11)
| Year | Studies |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2007 | 2 |
| 2008 | 11 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 12
- Phase 2
- 6
- Phase 3
- 35
- Phase 4
- 11
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 52 · Other 14
Sumitomo Pharma America, Inc. (37) · Sumitomo Pharma (Suzhou) Co., Ltd. (6) · Sumitomo Pharma Co., Ltd. (5) · Massachusetts General Hospital (2) · New York State Psychiatric Institute (2) · Bukwang Pharmaceutical (2) · Northwestern University (1) · Lakshmi N Yatham (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses lurasidone is read from its arms, and is right about nine times in ten.
Testing it · 66
- Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyNot yet recruitingPhase 3Bukwang PharmaceuticalNCT07781293Written as Lurasidone
- Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar DisorderNot yet recruitingPhase 4Martin LanNCT07806227Written as Lurasidone (Latuda)
- NRX-101 for Complicated Urinary Tract Infection (UTI) Including PyelonephritisNot yet recruitingPhase 2NeuroRx, Inc.NCT06128213Written as NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl (lurasidone))
- Chinese Longitudinal and Systematic Study of Bioplar DisorderRecruitingNot applicableFirst Affiliated Hospital of Zhejiang UniversityNCT05480150Written as Lurasidone
- Sequential Multiple Assignment Randomized Trial for Bipolar DepressionActive, not recruitingPhase 4Massachusetts General HospitalNCT06433635Written as Lurasidone
- High Dose Lurasidone for Patients With Treatment Resistant SchizophreniaCompletedPhase 4Northwestern UniversityNCT01569659Written as Lurasidone
- Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar PatientsCompletedPhase 3Lakshmi N YathamNCT02731612Written as lurasidone
- The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From OlanzapineTerminatedPhase 4Sumitomo Pharma (Suzhou) Co., Ltd.NCT05213143Written as Lurasidone
- The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With SchizophreniaCompletedPhase 4Sumitomo Pharma (Suzhou) Co., Ltd.NCT05011669Written as Lurasidone
- 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar DisorderCompletedPhase 4New York State Psychiatric InstituteNCT03902613Written as Lurasidone
- Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU)Status unknownPhase 4Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoNCT05351736Written as Lurasidone
- A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With SchizophreniaCompletedPhase 3Bukwang PharmaceuticalNCT03465787Written as Lurasidone HCL 160 mg
- A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I DepressionTerminatedPhase 3Sumitomo Pharma (Suzhou) Co., Ltd.NCT04383691Written as Lurasidone HCl
- A Phase III Study of SM-13496 in Patients With Bipolar I Depression.CompletedPhase 3Sumitomo Pharma Co., Ltd.NCT01986101Written as SM-13496
- Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedPhase 3Sumitomo Pharma Co., Ltd.NCT00711269Written as SM-13496 (lurasidone HCl)
- Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedPhase 3Sumitomo Pharma Co., Ltd.NCT01614912Written as SM-13496
- A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.CompletedPhase 3Sumitomo Pharma Co., Ltd.NCT01986114Written as SM-13496
- A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedPhase 3Sumitomo Pharma Co., Ltd.NCT01614899Written as SM-13496 40mg
- Lurasidone Effects on Tissue Glutamate in SchizophreniaCompletedPhase 4University of Texas Southwestern Medical CenterNCT02199743Written as Lurasidone
- A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With SchizophreniaCompletedPhase 1Sumitomo Pharma America, Inc.NCT03627195Written as DSP-1349M
See all 66 studies that test lurasidone →
Given in every arm · 2 — lurasidone is usual care beside what is tested
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic MedicationCompletedPhase 2Astellas Pharma Global Development, Inc.NCT03557931Written as lurasidone
- NRX101 Glx Biomarker Validation StudyCompletedPhase 2/3NeuroRx, Inc.NCT03402152Written as Lurasidone HCl
As the comparator · 3 — what is tested is compared with lurasidone
- NRX-101 for Bipolar Depression With Subacute Suicidal IdeationCompletedPhase 2/3NeuroRx, Inc.NCT03395392Written as Lurasidone HCl
- NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal IdeationActive, not recruitingPhase 3NeuroRx, Inc.NCT03396068Written as Lurasidone HCl
- Sequential Therapy for the Treatment of Severe Bipolar Depression.CompletedPhase 2NeuroRx, Inc.NCT02974010Written as Lurasidone Oral Capsule
Codes
What other systems call lurasidone · ClinicalTrials.gg INT006563
- MeSH (NLM) D000069056Lurasidone HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 22IC88528TLURASIDONEConfirmed FDA, NLM, Wikidata
- RxNorm 1040028Confirmed FDA, Wikidata
- Wikidata Q416992lurasidoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C77575LurasidoneOne source FDA
- DrugBank DB08815One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069056 | Lurasidone Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 22IC88528T | LURASIDONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1040028 | — | Confirmed FDA, Wikidata |
| Wikidata | Q416992 | lurasidone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C77575 | Lurasidone | One source FDA |
| DrugBank | DB08815 | — | One source Wikidata |
Also registered as lurasidone hydrochloride (UNII O0P4I5851I · RxNorm 1040027).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.